Association of LDL protein cargo with segmental pulse wave velocity in older adults in the atherosclerosis risk in

Binchong An1, Pamela L Lutsey2, Michelle M Mielke3

  • 1Department of Lab Medicine Pathology, University of Minnesota, Minneapolis, MN, United States.

Frontiers in Aging
|June 8, 2026
PubMed

Insights

Low-density lipoprotein (LDL) protein cargo, specifically apolipoprotein B (apoB) and complement component 3 (C3), show distinct associations with arterial stiffness measures like brachial-ankle pulse wave velocity (baPWV) and carotid-femoral PWV (cfPWV) in aging adults.

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Aging Research

Background:

  • Low-density lipoprotein cholesterol (LDL-C) is linked to brachial-ankle pulse wave velocity (baPWV), but associations with other pulse wave velocity (PWV) measures are inconsistent.
  • Low-density lipoprotein (LDL) particles contain not only lipids but also protein cargo, which may influence vascular health.

Purpose of the Study:

  • To investigate and compare the cross-sectional associations between LDL protein cargo and LDL-C with segment-specific PWV measures in an aging population.
  • To determine if LDL protein components offer different insights into arterial stiffness compared to LDL-C.

Main Methods:

  • Utilized data from 65 participants without dementia from the Atherosclerosis Risk in Communities (ARIC) study.
  • Quantified LDL cargo proteins using mass spectrometry-based proteomics.
  • Employed linear regression analysis, adjusting for covariates, to assess associations between LDL components (apoB, C3) and LDL-C with baPWV, femoral-ankle PWV (faPWV), and cfPWV.

Main Results:

  • Each SD increment of LDL apolipoprotein B (apoB) was associated with increased baPWV (103.0 cm/s, p=0.001).
  • Each SD increment of LDL complement component 3 (C3) was associated with increased cfPWV (80.9 cm/s, p=0.02).
  • LDL-C showed a positive association with baPWV (54.3 cm/s, p=0.08) and a negative association with cfPWV (-62.4 cm/s, p=0.04).

Conclusions:

  • LDL protein cargo, specifically apoB and C3, exhibit differential associations with arterial stiffness measures (baPWV and cfPWV).
  • These findings suggest that LDL protein composition may play a distinct role in vascular aging and arterial stiffness beyond LDL-C levels.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...